Orrick Herrington & Sutcliffe LLP advised FormFactor on the matter. FormFactor, Inc. (NASDAQ:FORM), a leading provider of essential test and measurement technologies, has entered into an agreement with...
Camtek’s Acquisition of FRT GmbH
Sosei Heptares’ U.S.$466 Million Acquisition of Idorsia’s Pharmaceuticals Business in Japan and APAC
Orrick advised Sosei Heptares. Sosei Heptares has announced its acquisition for U.S.$466 million (JPY 65 billion) of Idorsia’s pharmaceuticals business in Japan and APAC (ex-China). Sosei...
Databricks’ $1.3 Billion Acquisition of MosaicML
Orrick advised MosaicML on the deal. Databricks has entered into a definitive agreement to acquire MosaicML, a leading generative AI platform for approximately $1.3 billion. MosaicML...
Catalyst Biosciences’ Reverse Merger with GNI Group
Orrick advised Catalyst Biosciences, Inc. on the deal. South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. announced its acquisition of the F351 program, a next-generation fibrosis drug,...
COVA Acquisition’s $3.82 Billion De-Spac Merger with ECARX
UBS AG Hong Kong Branch(1) and Morgan Stanley Asia Limited acted as joint financial advisors to ECARX. Skadden, Arps, Slate, Meagher & Flom, together with Maples...